Elegen
Menlo Park
About Elegen
Elegen is a biotechnology company that develops microfluidic technology. It is driven by a mission to deploy this technology in a new generation of DNA synthesizers aimed at enabling and accelerating biomedical advances. The company was founded in 2017 and led by Dr. Matthew Hill.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.0M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2024)
- Website: elegenbio.com
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/elegen-727 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.